National Rates of Initiation and Intensification of Antidiabetic Therapy Among Patients With Commercial Insurance

Diabetes Care - United States
doi 10.2337/dc17-2585
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Indications of Initiation Renal Replacement Therapy Among Patients With Chronic Renal Disease

Health & Research Journal
2016English

Patterns and Trends in Insulin Initiation and Intensification Among Patients With Type 2 Diabetes Mellitus in the Middle East and North Africa Region

Diabetes Research and Clinical Practice
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2019English

Initiation and Completion Rates of Isoniazid Preventive Therapy Among People Living With HIV in Far-Western Region of Nepal: A Retrospective Cohort Study

BMJ Open
Medicine
2019English

Time to Initiation of Antiretroviral Therapy Among Patients With HIV-Associated Tuberculosis in Cape Town, South Africa

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2011English

Pdb111 - Trend and Factors Associated With Preventable Hospitalization Among Diabetes Mellitus Patients in a National Health Insurance Program

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Low Treatment Initiation Rates Among Multidrug-Resistant Tuberculosis Patients in Gauteng, South Africa, 2011

International Journal of Tuberculosis and Lung Disease
MedicinePulmonaryInfectious DiseasesRespiratory Medicine
2013English

Disparities in Survival Among Patients With Pancreatic Neuroendocrine Tumor Using the National Cancer Database: Effects of Insurance Status and Treatment Facility

HPB
HepatologyGastroenterology
2019English

Features of Commercial Risk Insurance

2019English

Impact of Site of Care on Infection Rates Among Patients With Primary Immunodeficiency Diseases Receiving Intravenous Immunoglobulin Therapy

Journal of Clinical Immunology
AllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy